about
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaiseIron chelation and multiple sclerosisPsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorCombinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiationExcitatory amino acid changes in the brains of rhesus monkeys following selective cerebral deep hypothermia and blood flow occlusion.Effects of oxygen-glucose deprivation on microglial mobility and viability in developing mouse hippocampal tissues.Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Activation of sodium-dependent glutamate transporters regulates the morphological aspects of oligodendrocyte maturation via signaling through calcium/calmodulin-dependent kinase IIβ's actin-binding/-stabilizing domain.Pathogenic implications of iron accumulation in multiple sclerosis.Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.Changes in gap junction expression and function following ischemic injury of spinal cord white matterOpposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosisNeurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication.Glutamate receptors: the cause or cure in perinatal white matter injury?The impact of commercially available purinergic ligands on purinergic signalling research.Roles of white matter in central nervous system pathophysiologies.Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.The axon-glia unit in white matter stroke: mechanisms of damage and recovery.Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.White Matter Neurons in Young Adult and Aged Rhesus MonkeyPathoetiology of multiple sclerosis: are we barking up the wrong tree?Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury.Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia.Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.P2X(7) receptors in cerebral ischemiaAre vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?NMDA Receptors in Glial Cells: Pending Questions.Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia.Neurotransmitter signaling in white matter.Redox Signaling in Neurotransmission and Cognition During Aging.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationIonotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex.Basal CD38/cyclic ADP-ribose-dependent signaling mediates ATP release and survival of microglia by modulating connexin 43 hemichannels.Chemokine fractalkine attenuates overactivation and apoptosis of BV-2 microglial cells induced by extracellular ATP.White matter damage after traumatic brain injury: A role for damage associated molecular patterns.TASK-1 channels in oligodendrocytes: a role in ischemia mediated disruptionEffects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury
P2860
Q27001628-608F8F28-4A64-40CF-9AB2-6A43787A85DAQ27001743-7C0E756F-4F24-4921-B814-6607C3925F93Q27694728-641D20C1-226D-436E-85B8-35F31B9F5318Q28544672-11EA20F5-08F0-4111-8FB8-1263B5C4A206Q30410789-E9E92155-FC8C-4240-9216-F07BA4D39C20Q30547682-A963A161-EE92-4CE2-A7EA-4273884273A8Q33898338-F77E381A-B576-4DE2-AA5D-15AD62D3E162Q33934115-26308DA4-5157-46FC-A48E-9B23E47F60F4Q34049616-CFE7C3EF-B86A-4050-8A91-6984C43183F1Q34151104-4F391270-B5F7-45C1-8C25-BCCC5D2EDD53Q34763071-876845BE-9B49-4B34-AEB0-95A050907BFBQ34807095-4DD20741-BD0E-413D-AC60-7A10D18D3DDAQ34844716-2AE2E65D-114B-4076-82D9-130E8E3562D7Q35632609-9AA9CC5F-285A-4F42-A56B-FDF2EFBAAC38Q35693550-9FF56D3C-C80F-430B-8922-51399FDEDB91Q35846494-68AC89ED-1060-4636-BB98-DE40EABFBADAQ35941437-FFE32906-76F5-4BFA-92D1-6EC4EC33733DQ35984483-C0444B85-DC98-4DCB-B907-5FB1F6347650Q36090107-0B769F79-D044-4402-B353-BB5857D1A95DQ36593234-8B832D36-1B88-4D29-8743-6ACEFC788E75Q36602151-7E2E8D6C-9541-4C6A-AD2D-77F4623DAD7FQ36904407-C8EDD701-A34F-4E20-8041-C94804B44879Q37089253-8B700252-7E9A-4D4F-9B4C-7C7FF7A0BA1FQ37128357-F2FE0B14-68B7-48A1-90D5-B31A13A395D9Q37150323-2A078C7D-AEC0-48AA-A482-6BC935842538Q37468719-C673F866-B8E3-4B2A-B07D-5056591EB8CBQ37586538-C58B2983-92E8-433F-B1D6-B80A3751E4D8Q38103774-112CAD28-95C6-4B39-AE2B-9452D78BBB62Q38134724-EC942432-2472-4BB1-B70C-14D4639BE5F5Q38157889-517BED1A-E705-4808-ADAD-FC751D83196DQ38202292-2CE7A9A8-B86E-4D19-A98F-0D925D15A714Q38206164-9E1BD773-52D6-4938-B821-1E6315E215A7Q38688126-03C13422-01CA-4582-A9C9-645A3D8FB58CQ38789322-3FC95F06-D7EA-4053-8128-5C5D55327A32Q38936972-86C2465A-633C-41B9-90B2-512D7AA9BB1AQ39020101-4C007DE6-BF75-4723-946F-5BC1EA7D5933Q39185958-4DFD3665-9537-461A-8ABB-15623D7F8B05Q39323255-F17E41F2-C112-4ECF-815E-5052032C454CQ40804122-017AC09E-072D-479B-87A7-E77B32EFFB2EQ41111184-9C47EE32-4423-439E-84F7-609A3C4CC1DE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glutamate and ATP signalling in white matter pathology.
@en
Glutamate and ATP signalling in white matter pathology.
@nl
type
label
Glutamate and ATP signalling in white matter pathology.
@en
Glutamate and ATP signalling in white matter pathology.
@nl
prefLabel
Glutamate and ATP signalling in white matter pathology.
@en
Glutamate and ATP signalling in white matter pathology.
@nl
P2860
P1433
P1476
Glutamate and ATP signalling in white matter pathology.
@en
P2093
Carlos Matute
P2860
P356
10.1111/J.1469-7580.2010.01339.X
P577
2011-01-20T00:00:00Z